European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Insulin tenders in Spain

Insulin tenders in Spain: 199 listed on GranTender since 2024. The median awarded contract value is about €1,200 (201 contracts with a stated value). Buyers with the most tenders: Servicio Cántabro de Salud (39), ICS - Hospital Universitari Germans Trias i Pujol (33) and Dirección Gerencia de Atención Primaria de Toledo (28); suppliers with the most contract awards: Liesno Buno SL (15), Abbott Laboratories, S.A. (15) and Embecta Medical Spain, SL (15). Sources: PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED. In 2025 the median contract value was €1,500. Data as of 18 November 2026; updated daily.

Tenders
199
Open tenders
0
Awards
233
Awarded value awarded
€20,078,612
Awarded value contract
€7,464,217
Awarded value framework ceiling
€12,808,433
Median contract value awarded
≈ €1,200
Median contract value contract
≈ €100,000
Median contract value framework ceiling
≈ €310,000
Average bids per contract
1.1
Tenders in 2025
66 +5% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
Contrato basado AM SCS 2023/74 para el suministro de material fungible de la diabetes mellitus tipo I, tipo II y otras patologías insulinodependientes para los usuarios del Servicio Cántabro de Salud de la comunidad autónoma de Cantabria. LOTE 1.Servicio Cántabro de Salud€52,668Awarded28 September 2026
Contrato basado AM SCS 2023/74 para el suministro de material fungible de la diabetes mellitus tipo I, tipo II y otras patologías insulinodependientes para los usuarios del Servicio Cántabro de Salud de la comunidad autónoma de Cantabria. LOTE 12.Servicio Cántabro de Salud€25,272Awarded25 September 2026
Contrato basado AM SCS 2023/74 para el suministro de material fungible de la diabetes mellitus tipo I, tipo II y otras patologías insulinodependientes para los usuarios del Servicio Cántabro de Salud de la comunidad autónoma de Cantabria. LOTE 1.Servicio Cántabro de Salud€33,858Awarded27 August 2026
Contrato basado AM SCS 2023/74 para el suministro de material fungible de la diabetes mellitus tipo I, tipo II y otras patologías insulinodependientes para los usuarios del Servicio Cántabro de Salud de la comunidad autónoma de Cantabria. LOTE 1.Servicio Cántabro de Salud€139,536Awarded18 June 2026
Contrato basado AM SCS 2023/74 para el suministro de material fungible de la diabetes mellitus tipo I, tipo II y otras patologías insulinodependientes para los usuarios del Servicio Cántabro de Salud de la comunidad autónoma de Cantabria. LOTE 1.Servicio Cántabro de Salud€50,274Awarded7 May 2026
Suministro de Dobutamina (DOE), Apremilast (DOE) e Insulina Glargina (DOE)OSAKIDETZA - Servicio Vasco de Salud -Director General€583,027Awarded9 April 2026
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IV. LOTE 1Servicio Cántabro de Salud€65,322Awarded6 March 2026
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IV. LOTE 1Servicio Cántabro de Salud€137,142Awarded24 February 2026
Suministro de Insulina Asparta (DOE) y Metilprednisolona (DOE) parenteralOSAKIDETZA - Servicio Vasco de Salud -Director General€1,933,291Closed2 February 2026
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IV. LOTE 1Servicio Cántabro de Salud€144,324Awarded9 July 2025
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IV. LOTE 1Servicio Cántabro de Salud€84,132Awarded8 July 2025
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IV. LOTE 1Servicio Cántabro de Salud€29,412Awarded8 July 2025
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IV. LOTE 1Servicio Cántabro de Salud€25,308Awarded8 July 2025
Suministro de Insulina soluble (DOE) e Insulina aspart (DOE)OSAKIDETZA - Servicio Vasco de Salud -Director General€828,600Awarded30 January 2025
Suministro de Insulina soluble (DOE), 13C Urea (DOE), Epoprostenol (DOE) y Bromuro de Ipratropio (DOE)OSAKIDETZA - Servicio Vasco de Salud - Organización Central—Awarded29 January 2025
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IVServicio Cántabro de Salud€25,308Awarded20 January 2025
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IVServicio Cántabro de Salud€94,392Awarded20 January 2025
Material fungible para el tratamiento integral de la diabetes y otras patologías insulinodependientes AM SCS 2023/74, G.A.E III y IVServicio Cántabro de Salud€26,676Awarded20 January 2025
Servicio de gestión integral de sistemas automatizados de infusión de insulina para los pacientes con DMT 1 del Servicio Riojano de Salud. Plan de Recuperación, Transformación y Resiliencia, financiado por la Unión Europea Next Generation EU.Servicio Riojano de Salud€4,545,979Awarded27 November 2024
Suministro de material fungible para el tratamiento integral de la Diabetes Mellitus tipo I, tipo II y otras patologías insulinodependientes para los usuarios del Servicio Cántabro de SaludServicio Cántabro de Salud€35,076,222Awarded5 June 2024

Competition and prices

In 2025, half of the contracts were worth between €240 and €11,000, with a median of €1,500 (53 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 25%. The usual procedures: direct award (65%), open procedure (21%), other procedures (13%) — of 131 tenders with a stated procedure.

The most contracts went to Liesno Buno SL (15), Abbott Laboratories, S.A. (15) and Embecta Medical Spain, SL (15) — together 19% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
202489€1,200€220 – €6,1001.281% (31)
202554€1,500€240 – €11,000——
2026 (so far)59€1,200€310 – €5,5001.196% (27)
All years233€1,200€240 – €8,7001.190% (77)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 98% of the 44 contracts with a known number of bids had a single bid; the median was 1 bid. The number of bids is known for 44 of the 88 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

BuyerContracts with known bidsMedian bidsSingle bid
Servicio Cántabro de Salud361100%

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 52 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33615000 Medicinal products used in diabetes

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Insulin and antidiabetic drugs in neighbouring countries

No tender in the same niche is open today in neighbouring countries; 83 were published there since 2024.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon2

ExpectedBuyerWhatWhy we expect itConfidence
now – Dec 2026
contract ends
Servicio de Salud - Servicios CentralesInsulin and antidiabetic drugs
Ccompras_Suministro de agujas para plumas o bolígrafos de insulina
Typical value: ≈ €6,300
The current contract with MERCK LIFE SCIENCE S.L.U. ends on 31 December 2026; no new tender has been published yet.
Earlier tenders: 02/2024
medium
Jan – Feb 2027
every year
OSAKIDETZA - Servicio Vasco de Salud -Director GeneralInsulin and antidiabetic drugs
Suministro de Insulina Asparta (DOE) y Metilprednisolona (DOE) parenteral
Typical value: ≈ €86,000
The buyer has published insulin tenders every year in February since 2025. The current contract with TARBIS FARMA S.L. ends on 17 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 02/2026, 01/2025, 04/2026
high

Forecast from public data, not an announcement. Methodology.

Market reports

Insulin and antidiabetic drugs by city

Insulin and antidiabetic drugs in other countries

Insulin and antidiabetic drugs across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Where can I find insulin tenders in Spain?
GranTender lists them in one place, from PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most insulin tenders in Spain?
By number of contracts won: Liesno Buno SL (15), Abbott Laboratories, S.A. (15), Embecta Medical Spain, SL (15).
Which buyers publish the most insulin tenders in Spain?
By number of tenders: Servicio Cántabro de Salud (39), ICS - Hospital Universitari Germans Trias i Pujol (33), Dirección Gerencia de Atención Primaria de Toledo (28).
Which CPV codes belong to “Insulin and antidiabetic drugs”?
33615000 Medicinal products used in diabetes; plus tenders without a usable CPV code whose title names the topic.
How much are contracts for insulin tenders in Spain worth?
In 2025, half of the contracts were worth between €240 and €11,000, with a median of €1,500 (53 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 25%.
Which procedures are used for insulin tenders in Spain?
The usual procedures: direct award (65%), open procedure (21%), other procedures (13%) — of 131 tenders with a stated procedure.
Which buyers get few offers in insulin tenders in Spain?
Since 1 November 2024, these buyers usually received one or two offers per contract: Servicio Cántabro de Salud (median 1 bid over 36 contracts). Since 1 November 2024, 98% of the 44 contracts with a known number of bids had a single bid; the median was 1 bid.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.